Plant Cell Culture Harvest Timing Patents: Leaders & White Space 2026
Plant Cell Culture Harvest Timing Patents: Who Holds the Filings, and Where They Thin Out
One assignee dominates the ranked field. the leader holds 23 records against a fifth-place count of 2 and a tenth-place count of 1, leaving an unusually long single-filer tail. Filings peaked at 7 in 2018. The tracked growth window shows 2 filings in 2021 falling to 0 in 2024, a -100% change over that three-year span — the most recent complete-year comparison available in this dataset. 2025 and 2026 figures are still filling in due to publication lag and should not be read against this trend.
- 1DUDA A & SONS INC23
- 2AMGEN INC8
- 3SYNGENTA PARTICIPATIONS AG5
- 4KALAMAZOO HLDG INC3
- 5GINKGO BIOWORKS INC2
See the full plant cell culture harvest timing analysis in Eureka
- The complete ranking, not just the top five
- Every IPC branch with its share of the corpus
- The most-cited records, and where claim space is still thin
Common questions on this landscape
Who holds the most patents in plant cell culture harvest timing?
One assignee leads the ranked field with 23 records, well ahead of the rest of the eleven companies tracked in this dataset. Fifth place holds only 2 records and tenth place holds 1, so the field is best described as one dominant filer plus a long tail of single-record entrants rather than several competing leaders. That leader’s portfolio is built substantially on named cultivar filings, such as celery and lettuce varieties, rather than on bioreactor process claims.
Is filing activity in this field growing or shrinking?
Filings peaked at 7 in 2018 and the most recent complete-year comparison, 2021 to 2024, shows a full -100% drop to zero. That said, publication lags actual filing by roughly 18 months, so 2025 and 2026 figures in any such dataset are still incomplete and should not be read as confirming a live decline. The honest read is that the field cooled sharply after its 2018 peak, with the post-2024 picture not yet resolved.
What technology areas do these patents actually claim?
The large majority of records sit in C12N (microorganisms and genetic engineering, 95.7% of the 47 records) and A01H (new plants and plant breeding, 76.6%), meaning most claims describe cultivars, breeding methods or genetic modifications rather than bioreactor hardware. C12M, the bioreactor and enzyme-apparatus class, covers only 25.5% of records. Because a single record can carry several IPC classes, these percentages add to more than 100% and should not be treated as parts of a whole.
Disclaimer. This analysis is based on Patsnap Eureka data drawn from a limited snapshot of global patent records and is provided for general information and reference only. Patent data carries inherent limitations — recent filings are under-counted because of publication lag, counts may be on a record or family basis, classification and applicant-name data may contain errors or duplicates, and the underlying search query defines the scope shown — so the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing here is an exhaustive prior-art, novelty, freedom-to-operate or validity search, nor does it constitute legal, financial or professional advice, and it should not be relied upon as such. Verify independently and review with qualified patent and legal professionals before acting on it.
Method: Filing trend and technology composition. Derived from a Patsnap search on Plant Cell Culture Harvest Timing covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish. Every share divides by all records in scope. Data: Patsnap Eureka. See the full landscape report.